Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs.
The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs. Cells. 2021 01 12; 10(1).
View in:
PubMed
subject areas
Cell Line, Tumor
Cetuximab
Cyclin-Dependent Kinase 8
Cyclin-Dependent Kinases
Drug Resistance, Neoplasm
ErbB Receptors
Erlotinib Hydrochloride
Humans
Inhibitory Concentration 50
Molecular Targeted Therapy
Protein Kinase Inhibitors
authors with profiles
Igor Roninson